[AQST] YoY Quarter Result on 30-Jun-2018 [#Q2]

Stock
[AQST] Aquestive Therapeutics, Inc.
Announcement Date
04-Sep-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q2]
Profit Trend
QoQ- -990.29%
YoY- -518.84%
Quarter Report
AQST's Result
AQST's Financial Summary
View:
Show?
Quarter Result
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Revenue 13,241 13,265 15,345 21,675 11,129 13,928 11,142 2.91%
PBT -5,508 -16,302 -12,367 -2,334 -20,472 -36,493 -5,897 -1.13%
Tax 284 3,540 373 18 153 1,129 1,949 -27.44%
NP -5,792 -19,842 -12,367 -2,334 -20,472 -36,493 -5,897 -0.29%
Tax Rate - - - - - - - -
Total Cost 19,033 33,107 27,712 24,009 31,601 50,421 17,039 1.86%
Ratio Analysis
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
NP Margin -43.74 -149.58 -80.59 -10.77 -183.95 -262.01 -52.93 -3.12%
Per Share
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
EPS -0.10 -0.44 -0.33 -0.07 -0.82 -1.52 -0.29 -16.25%
EPS Diluted -0.10 -0.44 -0.33 -0.07 -0.82 -1.52 -0.29 -16.25%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.